{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:22:21Z","timestamp":1793395341968,"version":"4.5.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:p>\n                    MELF invasion has been associated with nonvaginal recurrences and lymph node (LN) metastases in multi-institutional case control studies but has not been well examined in large single-institution cohorts. Hysterectomy specimens with FIGO 1 endometrioid endometrial carcinoma and lymphadenectomies from 2007 to 2012 were identified. Electronic medical records and histologic slides were reviewed. Of 464 identified cases, 163 (35.1%) were noninvasive, 60 (12.9%) had MELF, 222 (47.8%) had a component of the infiltrative invasion pattern without MELF, 13 (2.8%) had pure pushing borders of invasion, 5 (1.1%) had pure adenomyosis-like invasion, and 1 (0.2%) had pure adenoma malignum-like invasion. Sixteen cases had LN metastases. Significantly more MELF cases had positive LNs than non-MELF cases overall (18.3% vs. 1.2%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.001). The results were almost identical when invasive infiltrative cases with and without MELF were compared (18.3% vs. 1.8%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.001). The maximum number of MELF glands per slide did not differ between cases with and without LN metastases,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.137. A majority of positive LNs, even in MELF cases, demonstrated nonhistiocyte-like metastases. Only 5 cases (all with MELF invasion) demonstrated micrometastatic lesions or isolated tumor cells only. MELF cases demonstrated a nonsignificant decrease in time to extravaginal recurrence (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.082, log-rank test), for which analysis was limited by low recurrence rates. In summary, MELF is associated with LN metastases, even when compared with other infiltrative cases and shows multiple patterns of growth in positive LNs. MELF cases additionally trended toward decreased time to extravaginal recurrence.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000000754","type":"journal-article","created":{"date-parts":[[2016,10,13]],"date-time":"2016-10-13T12:12:12Z","timestamp":1476360732000},"page":"49-55","source":"Crossref","is-referenced-by-count":55,"title":["The Microcystic, Elongated, and Fragmented (MELF) Pattern of Invasion"],"prefix":"10.1097","volume":"41","author":[{"given":"Amy S.","family":"Joehlin-Price","sequence":"first","affiliation":[{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey E.","family":"McHugh","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Stephens","sequence":"additional","affiliation":[{"name":"Center for Biostatistics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaibo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floor J.","family":"Backes","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Cohn","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian A.","family":"Suarez","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ygyno.2007.05.033","article-title":"The outcomes of 27,063 women with unstaged endometrioid uterine cancer","volume":"106","author":"Chan","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1158\/1055-9965.EPI-15-1145","article-title":"Endometrial cancer insulin-like growth factor 1 receptor (IGF1R) expression increases with body mass index and is associated with pathologic extent and prognosis","volume":"25","author":"Joehlin-Price","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ygyno.2011.01.027","article-title":"Obesity in relation to endometrial cancer risk and disease characteristics in the Women\u2019s Health Initiative","volume":"121","author":"Reeves","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ygyno.2014.06.003","article-title":"Endometrial cancer: a review and current management strategies: Part II","volume":"134","author":"Burke","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/PAP.0b013e31828d17cc","article-title":"Patterns of myoinvasion in endometrial adenocarcinoma: recognition and implications","volume":"20","author":"Cole","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/PGP.0b013e31823ff422","article-title":"Low grade, low stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion","volume":"31","author":"Quick","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/PGP.0b013e318285657b","article-title":"Lymphovascular space invasion in microcystic elongated and fragmented (MELF)-pattern well differentiated endometrioid adenocarcinoma is associated with a higher rate of lymph node metastasis","volume":"33","author":"Hertel","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1080\/00313020903041135","article-title":"MELF pattern invasion in endometrial carcinoma: association with low grade, Myoinvasive endometrioid tumors, focal mucinous differentiation and vascular invasion","volume":"41","author":"Stewart","year":"2009","journal-title":"Pathol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1365-2559.2011.03802.x","article-title":"MELF invasion in endometrial cancer as a risk factor for lymph node metastasis","volume":"58","author":"Pavlakis","year":"2011","journal-title":"Histopathology"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/his.12254","article-title":"Histologic features associated with occult lymph node metastasis in FIGO clinical stage I, grade I endometrioid carcinoma","volume":"64","author":"Han","year":"2014","journal-title":"Histopathology"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/01443615.2014.960827","article-title":"The association of the microcystic, elongated, and fragmented (MELF) invasion pattern in endometrial carcinomas with deep myometrial invasion, lymphovascular space invasion and lymph node metastasis","volume":"35","author":"Dogan Altunpulluk","year":"2015","journal-title":"J Obstet Gynaecol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/gyno.1994.1158","article-title":"Traditional and nontraditional histopathologic predictors of recurrence in uterine endometrioid adenocarcinoma","volume":"54","author":"Lee","year":"1994","journal-title":"Gynecol Oncol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/01.pgp.0000092161.33490.a9","article-title":"Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance","volume":"22","author":"Murray","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.prp.2010.10.005","article-title":"CD147 (EMMPRIN) and matrix metalloproteinase-2 expression in uterine endometrioid adenocarcinoma","volume":"207","author":"Stewart","year":"2011","journal-title":"Pathol Res Pract"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/PGP.0b013e3181e4ee4ea","article-title":"Galectin-3 expression in uterine endometrioid adenocarcinoma: comparison of staining in conventional tumor glands and in areas of MELF pattern myometrial invasion","volume":"29","author":"Stewart","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00125480-200205000-00001","article-title":"Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects","volume":"9","author":"Clement","year":"2002","journal-title":"Adv Anat Pathol"},{"key":"R19-20230922","first-page":"73","article-title":"Endometrial adenocarcinoma associated with subtle lymph-vascular space invasion and lymph node metastasis: a histologic pattern mimicking intravascular and sinusoidal histiocytes","volume":"24","author":"McKenney","year":"2005","journal-title":"Int J Gynecol Pathol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1097\/PAS.0b013e318299f2ab","article-title":"The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low grade endometrial carcinoma","volume":"37","author":"Euscher","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R22-20230922","first-page":"619","article-title":"Detection and importance of micrometastases histologically negative lymph nodes in endometrial carcinoma","volume":"32","author":"Erkanli","year":"2011","journal-title":"Eur J Gynaec Oncol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/IGC.0000000000000408","article-title":"The incidence and clinical significance of micrometastases in the sentinel lymph nodes during surgical staging for early endometrial cancer","volume":"25","author":"Ferraioli","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"R24-20230922","first-page":"181","article-title":"The incidence and clinical significance of lymph node micrometastases determined by immunohistochemical staining in stage I \u2013 lymph node negative endometrial cancer","volume":"27","author":"McCoy","year":"2012","journal-title":"Histol Histopathol"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3802\/jgo.2016.27.e1","article-title":"Isolated tumor cells and micrometastases in regional lymph nodes in stage I to II endometrial cancer. J","volume":"27","author":"Todo","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/PGP.0b013e31829c6757","article-title":"Risk factors for recurrence and prognosis of low-grade endometrial adenocarcinoma; vaginal versus other sites","volume":"33","author":"Moschiano","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R27-20230922","first-page":"67","article-title":"Cancer Genome Atlas Research Network","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br J Cancer"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201701000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T18:28:13Z","timestamp":1695407293000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201701000-00005"}},"subtitle":["A Single Institution Report of 464 Consecutive FIGO Grade 1 Endometrial Endometrioid Adenocarcinomas"],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000754","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}